Toggle navigation
Home
Search
Services
Blog
Contact
About
Intrabody Control of Expanded-Repeat Neurodegeneration
Messer, Anne
Intraimmune Therapies, Inc., Boston, MA, United States
Search 27 grants from Anne Messer
Search grants from Intraimmune Therapies, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Role of TGFB signaling in muscle regeneration and various myopathic states
Climate, Drought, and Agricultural Adaptations: An Investigation of Vulnerabilities and Responses to Water Stress Among Paddy Farmers in Sri Lanka
Investigations of a 17th-Century Spanish New Mexican Household: Social and Environmental Correlates of Colonization
Striking a Balance between Engineering Science and Engineering Design: Development of an Engineering Systems and Design Program
The Edison Link
Recently added grants:
Dissecting the pathways controlling tunable responses to TCR signaling
Wimpy antibody isotypes protect against antibody-mediated disease
Epigenome-wide association study of childhood asthma
Fungal and Host Factors in Initiation of Cryptococcal Persistence
Decreasing antibiotic prescribing in acute respiratory infections through implementation of nurse driven clinical decision support
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Technology Transfer (STTR) Grants - Phase II (R42)
Project #
2R42NS038002-02
Application #
6073705
Study Section
Special Emphasis Panel (ZRG1-MDCN-3 (02))
Program Officer
Oliver, Eugene J
Project Start
1998-08-01
Project End
2002-01-31
Budget Start
2000-02-15
Budget End
2001-01-31
Support Year
2
Fiscal Year
2000
Total Cost
$250,000
Indirect Cost
Institution
Name
Intraimmune Therapies, Inc.
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02114
Related projects
NIH 2001
R42 NS
Intrabody Control of Expanded-Repeat Neurodegeneration
Messer, Anne / Abgenix, Inc.
$250,000
NIH 2000
R42 NS
Intrabody Control of Expanded-Repeat Neurodegeneration
Messer, Anne / Intraimmune Therapies, Inc.
$250,000
Comments
Be the first to comment on Anne Messer's grant